Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

NCT04312789 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Drug availability

Conditions

Platelet Disorder

Interventions

DRUG: Avatrombopag

Sponsor

Ayman Saad

Collaborators

[object Object]